Skip to main content
PolicySpeak
← All files
BC

Biocontrol Coalition

Other · Belgium · EU Transparency Register 715938853121-73

2
positions filed
in the 326 files tracked
2
legislative files
of 326 tracked
2
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 145 other organisations on this site, they rank #62 by legislative files engaged — a count of participation, not a measure of influence.

0.8
declared lobbying FTE
self-declared
€100K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2024
in the register since
Register category
Other organisations
Head office
Antwerpen, Belgium
EU office
Brussels

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track Biocontrol in PolicySpeak: request access →

Work at Biocontrol Coalition? so we know who speaks for it.

Follow the files Biocontrol Coalition engages with

One email on Tuesdays when a new position is filed on these 2 files, from Biocontrol Coalition or from anyone else on them. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

Biocontrol Coalition filed 2 positions between 11 Jun 2025 and 9 Jun 2026, across 2 of the 326 legislative files tracked here, attaching a full position paper 2 times.

2025 · 1 filed2026 · 1 filed

What they argued

European Biotech Actfiled 11 Jun 2025PDFsource

The Biocontrol Coalition argues that the current EU regulatory framework under Regulation (EC) 1107/2009 is ill-suited for biocontrol products, which are essential for sustainable agriculture. The fragmented, system built for chemistry-based products hinders innovation, delays market entry, and disproportionately affects SMEs.

Biotech Act IIfiled 9 Jun 2026PDFsource

The Biocontrol Coalition welcomes the opportunity to contribute to the European Commissions Call for Evidence on the Biotech Act II. The submission argues that the EU is not delivering sufficiently rapid and scalable access to biocontrol solutions despite repeated commitments on competitiveness, innovation and simplification.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Turns up on the same files

Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.

Showing 5 of 80.

Is this your organization?

Everything on this page comes from Biocontrol Coalition’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.